Health
AstraZeneca U.S. COVID-19 vaccine trial results likely in late-January, says health official – Reuters
AstraZeneca Plc will likely get results of its U.S. COVID-19 vaccine trial in late-January and could potentially file for an emergency authorization, the chief…
By Reuters Staff
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo
(Reuters) – AstraZeneca Plc will likely get results of its U.S. COVID-19 vaccine trial in late-January and could potentially file for an emergency authorization, the chief adviser for the U.S. governments Operation Warp Speed program said on Wednesday.
The British drugmaker…
-
General12 hours agoTributes flow after Australian Paralympic bronze medallist Nicholas Hum dies aged 32
-
Business21 hours agoWhat a rising Aussie dollar means for your ASX shares
-
Noosa News16 hours agoThree people rushed to hospital after Spring Hill unit fire
-
General22 hours agoAussies skipping dental, medical care to afford rent